Antiproteases attenuate the release of neutrophil chemotactic activity from bronchial epithelial cells induced by smoke

Sekiya Koyama, Stephen I. Rennard, George D. Leikauf, Ronald F. Ertl, Richard A. Robbins

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The released neutrophil chemotactic activity (NCA) from bronchial epithelial cells (BECs) in response to smoke extract was evaluated by reverse-phase, high-performance liquid chromatography (RP-HPLC) and the involvement of proteolytic activity was assessed for the release of NCA from BECs. Smoke extract stimulated the release of NCA (55.3 ± 5.2 vs. 17.3 ± 4.1 cells per high-power field [HPF], p < .001). The released activity determined by RP- HPLC analysis was 15-hydroxyeicosatetraenoic acid and leukotriene B4. Several structurally and functionally different serine protease inhibitors, including α-1-protease inhibitor (α-1-PI), chloromethyl ketone (CK) derivatives. N-tosyl-L-lysine CK (TLCK), methylsuccinyl-Ala-Ala-Pro-Val CK (SPCK). N-α-tosyl-L- phenylalanine CK (TPCK), and N-α-p-tosyl-L-arginine methyl ester hydrochloride (TAME), attenuated the release of NCA (p < .01) in a dose-dependent fashion. Leupeptin, a cysteine protease inhibitor, has only a small effect on the release of NCA (p < .05), and phosphoramidon, a neutral endopeptidase inhibitor, had no effect. The measurement of proteolytic enzyme activity using synthetic substrate S-2288 revealed that smoke extract significantly (p < .05) augmented the serine protease activity in BEC layers. Culture supernatant fluids and cell lysates of BECs in response to smoke extract solubilized 14C-labeled casein. These results suggest that BECs may release lipoxygenase-derived NCA in response to smoke extract and that the release of NCA may involve the activation of proteolytic activity of BECs which was inhibited by serine protease inhibitors.

Original languageEnglish (US)
Pages (from-to)1-19
Number of pages19
JournalExperimental Lung Research
Volume22
Issue number1
DOIs
StatePublished - Jan 1 1996

Fingerprint

Protease Inhibitors
Smoke
Neutrophils
Epithelial Cells
Ketones
Serine Proteinase Inhibitors
isoleucyl-prolyl-arginine-4-nitroanilide
Cysteine Proteinase Inhibitors
Hydroxyeicosatetraenoic Acids
Neprilysin
High Pressure Liquid Chromatography
Leukotriene B4
Lipoxygenase
High performance liquid chromatography
Enzyme activity
Serine Proteases
Caseins
Phenylalanine
Lysine
Peptide Hydrolases

Keywords

  • bronchial epithelial cells
  • neutrophil chemotactic activity
  • serine protease inhibitor
  • smoking

ASJC Scopus subject areas

  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Clinical Biochemistry

Cite this

Antiproteases attenuate the release of neutrophil chemotactic activity from bronchial epithelial cells induced by smoke. / Koyama, Sekiya; Rennard, Stephen I.; Leikauf, George D.; Ertl, Ronald F.; Robbins, Richard A.

In: Experimental Lung Research, Vol. 22, No. 1, 01.01.1996, p. 1-19.

Research output: Contribution to journalArticle

Koyama, Sekiya ; Rennard, Stephen I. ; Leikauf, George D. ; Ertl, Ronald F. ; Robbins, Richard A. / Antiproteases attenuate the release of neutrophil chemotactic activity from bronchial epithelial cells induced by smoke. In: Experimental Lung Research. 1996 ; Vol. 22, No. 1. pp. 1-19.
@article{dc7501619a2b465bb39ced807067d9b3,
title = "Antiproteases attenuate the release of neutrophil chemotactic activity from bronchial epithelial cells induced by smoke",
abstract = "The released neutrophil chemotactic activity (NCA) from bronchial epithelial cells (BECs) in response to smoke extract was evaluated by reverse-phase, high-performance liquid chromatography (RP-HPLC) and the involvement of proteolytic activity was assessed for the release of NCA from BECs. Smoke extract stimulated the release of NCA (55.3 ± 5.2 vs. 17.3 ± 4.1 cells per high-power field [HPF], p < .001). The released activity determined by RP- HPLC analysis was 15-hydroxyeicosatetraenoic acid and leukotriene B4. Several structurally and functionally different serine protease inhibitors, including α-1-protease inhibitor (α-1-PI), chloromethyl ketone (CK) derivatives. N-tosyl-L-lysine CK (TLCK), methylsuccinyl-Ala-Ala-Pro-Val CK (SPCK). N-α-tosyl-L- phenylalanine CK (TPCK), and N-α-p-tosyl-L-arginine methyl ester hydrochloride (TAME), attenuated the release of NCA (p < .01) in a dose-dependent fashion. Leupeptin, a cysteine protease inhibitor, has only a small effect on the release of NCA (p < .05), and phosphoramidon, a neutral endopeptidase inhibitor, had no effect. The measurement of proteolytic enzyme activity using synthetic substrate S-2288 revealed that smoke extract significantly (p < .05) augmented the serine protease activity in BEC layers. Culture supernatant fluids and cell lysates of BECs in response to smoke extract solubilized 14C-labeled casein. These results suggest that BECs may release lipoxygenase-derived NCA in response to smoke extract and that the release of NCA may involve the activation of proteolytic activity of BECs which was inhibited by serine protease inhibitors.",
keywords = "bronchial epithelial cells, neutrophil chemotactic activity, serine protease inhibitor, smoking",
author = "Sekiya Koyama and Rennard, {Stephen I.} and Leikauf, {George D.} and Ertl, {Ronald F.} and Robbins, {Richard A.}",
year = "1996",
month = "1",
day = "1",
doi = "10.3109/01902149609074014",
language = "English (US)",
volume = "22",
pages = "1--19",
journal = "Experimental Lung Research",
issn = "0190-2148",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Antiproteases attenuate the release of neutrophil chemotactic activity from bronchial epithelial cells induced by smoke

AU - Koyama, Sekiya

AU - Rennard, Stephen I.

AU - Leikauf, George D.

AU - Ertl, Ronald F.

AU - Robbins, Richard A.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - The released neutrophil chemotactic activity (NCA) from bronchial epithelial cells (BECs) in response to smoke extract was evaluated by reverse-phase, high-performance liquid chromatography (RP-HPLC) and the involvement of proteolytic activity was assessed for the release of NCA from BECs. Smoke extract stimulated the release of NCA (55.3 ± 5.2 vs. 17.3 ± 4.1 cells per high-power field [HPF], p < .001). The released activity determined by RP- HPLC analysis was 15-hydroxyeicosatetraenoic acid and leukotriene B4. Several structurally and functionally different serine protease inhibitors, including α-1-protease inhibitor (α-1-PI), chloromethyl ketone (CK) derivatives. N-tosyl-L-lysine CK (TLCK), methylsuccinyl-Ala-Ala-Pro-Val CK (SPCK). N-α-tosyl-L- phenylalanine CK (TPCK), and N-α-p-tosyl-L-arginine methyl ester hydrochloride (TAME), attenuated the release of NCA (p < .01) in a dose-dependent fashion. Leupeptin, a cysteine protease inhibitor, has only a small effect on the release of NCA (p < .05), and phosphoramidon, a neutral endopeptidase inhibitor, had no effect. The measurement of proteolytic enzyme activity using synthetic substrate S-2288 revealed that smoke extract significantly (p < .05) augmented the serine protease activity in BEC layers. Culture supernatant fluids and cell lysates of BECs in response to smoke extract solubilized 14C-labeled casein. These results suggest that BECs may release lipoxygenase-derived NCA in response to smoke extract and that the release of NCA may involve the activation of proteolytic activity of BECs which was inhibited by serine protease inhibitors.

AB - The released neutrophil chemotactic activity (NCA) from bronchial epithelial cells (BECs) in response to smoke extract was evaluated by reverse-phase, high-performance liquid chromatography (RP-HPLC) and the involvement of proteolytic activity was assessed for the release of NCA from BECs. Smoke extract stimulated the release of NCA (55.3 ± 5.2 vs. 17.3 ± 4.1 cells per high-power field [HPF], p < .001). The released activity determined by RP- HPLC analysis was 15-hydroxyeicosatetraenoic acid and leukotriene B4. Several structurally and functionally different serine protease inhibitors, including α-1-protease inhibitor (α-1-PI), chloromethyl ketone (CK) derivatives. N-tosyl-L-lysine CK (TLCK), methylsuccinyl-Ala-Ala-Pro-Val CK (SPCK). N-α-tosyl-L- phenylalanine CK (TPCK), and N-α-p-tosyl-L-arginine methyl ester hydrochloride (TAME), attenuated the release of NCA (p < .01) in a dose-dependent fashion. Leupeptin, a cysteine protease inhibitor, has only a small effect on the release of NCA (p < .05), and phosphoramidon, a neutral endopeptidase inhibitor, had no effect. The measurement of proteolytic enzyme activity using synthetic substrate S-2288 revealed that smoke extract significantly (p < .05) augmented the serine protease activity in BEC layers. Culture supernatant fluids and cell lysates of BECs in response to smoke extract solubilized 14C-labeled casein. These results suggest that BECs may release lipoxygenase-derived NCA in response to smoke extract and that the release of NCA may involve the activation of proteolytic activity of BECs which was inhibited by serine protease inhibitors.

KW - bronchial epithelial cells

KW - neutrophil chemotactic activity

KW - serine protease inhibitor

KW - smoking

UR - http://www.scopus.com/inward/record.url?scp=0030052644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030052644&partnerID=8YFLogxK

U2 - 10.3109/01902149609074014

DO - 10.3109/01902149609074014

M3 - Article

C2 - 8838132

AN - SCOPUS:0030052644

VL - 22

SP - 1

EP - 19

JO - Experimental Lung Research

JF - Experimental Lung Research

SN - 0190-2148

IS - 1

ER -